Algo version: 0.98b
INO is listed at the NASDAQ Exchange
INO [INO]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is INO stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Inovio Pharmaceuticals pays dividends. Last time was Monday 16th of October 2017 where the investors holding the stock on Thursday 28th of September 2017 were paid $0.00570 per share. Over the last 4 times between 2017 and 2017, Inovio Pharmaceuticals has paid $0.0228 with an average of $0.01 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Inovio Pharmaceuticals 10 years ago, but if you had invested on Monday 8th of September 2014 when the price was $126.48, you would have made a loss of $-120.20 per share or -95.03%

Yes, the average daily trading liquidity for Inovio Pharmaceuticals is $3.38 million. You should therefore be able to get in and out of your positions relatively fast.

Inovio Pharmaceuticals has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Inovio Pharmaceuticals to be high [0.85 out of 1]